New York’s Child-Resistant Cannabis Packaging Law Fails to Reduce Pediatric Ingestions, Study Finds

BOSTON — A New York law that required cannabis products be sold in child-resistant packaging did not reduce the number of accidental ingestions among kids, according to a presenter at the Pediatric Academic Societies annual meeting.

The finding was presented on April 25, 2026, during the Pediatric Academic Societies annual meeting in Boston, where researchers shared data showing that despite the implementation of mandatory child-resistant packaging requirements for cannabis products in New York in 2023, rates of unintentional pediatric cannabis ingestions continued to rise.

As more states have legalized recreational marijuana, exposures among children have increased rapidly, especially with edible cannabis products that can resemble common snacks or candies.

“The most serious symptoms associated with pediatric cannabis consumption are hypoventilation, unresponsiveness/lethargy and seizure-like activity,” said Annamarie Fernandes, MD, FAAP, FACP, assistant professor of medicine and pediatrics at a medical institution referenced in the original reporting, though her specific affiliation was not fully detailed in the available source material.

Clinical summaries from multiple verified sources indicate that the study examined the impact of New York’s child-resistant packaging law, which required all cannabis sales to use compliant packaging, and found that the incidence of accidental cannabis ingestions in children remained unchanged after the law took effect.

The outcome suggests that packaging alone is insufficient to prevent pediatric exposures, likely because the risk factors driving accidental ingestions involve storage practices, parental supervision, and product accessibility in the home rather than container design.

Experts note that child-resistant containers must be opened by consumers and may be left accessible in home environments, reducing their effectiveness if products are not stored securely after use.

The findings highlight a critical gap between regulatory interventions and real-world harm prevention, indicating that compliance with packaging requirements does not eliminate the risk of accidental pediatric exposure.

Clinicians treating pediatric cannabis exposures in New York and other states with similar regulations should understand that relying solely on packaging mandates is inadequate for preventing unintentional ingestions.

Healthcare providers are advised to emphasize secure storage practices beyond packaging compliance, including keeping all cannabis products in locked containers or locations inaccessible to children, as part of routine patient counseling.

caregivers should be educated about poison control resources and the importance of recognizing signs of unintentional cannabis ingestion, such as sudden lethargy, difficulty breathing, or altered mental status in children.

Public health officials may need to consider complementary strategies, such as community awareness campaigns and targeted education for parents and caregivers, to address the behavioral and environmental factors that contribute to pediatric cannabis exposures.

The study reinforces that while child-resistant packaging is a necessary component of safety efforts, it must be paired with education on safe storage and supervision to meaningfully reduce the risk of harm to children.

As cannabis legalization expands across the United States, ongoing surveillance and evaluation of prevention strategies will be essential to protect children from accidental exposure to THC-containing products.